Evidence-based Mobile Medical Applications in Diabetes

Andjela Drincic, Priya Prahalad, Deborah Greenwood, David C. Klonoff

Research output: Contribution to journalReview articlepeer-review

43 Scopus citations


This article reviews mobile medical applications that are commercially available in the United States or European Union (EU) and are (1) associated with published data of clinical outcomes in the peer-reviewed literature during the past 5 years, (2) cleared by the US Food and Drug Administration (FDA) in the United States, or (3) a recipient of a CE (Conformité Européenne) mark by the EU. Many of these applications have been shown to positively affect outcomes in the short term, but long-term studies are needed. Until more data are available, consumers and professionals can consider guidance based on FDA/CE status.

Original languageEnglish (US)
Pages (from-to)943-965
Number of pages23
JournalEndocrinology and Metabolism Clinics of North America
Issue number4
StatePublished - Dec 1 2016


  • Applications
  • Diabetes
  • Glucose
  • Medical
  • Mobile
  • Telemedicine
  • mHealth

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Evidence-based Mobile Medical Applications in Diabetes'. Together they form a unique fingerprint.

Cite this